Probiotics and Obesity: The Therapeutic Potential of Lactobacillus gasseri SBT2055
Obesity is an ever-growing problem in today’s world. This disease serves as a significant public health burden in Canada, costing billions of dollars annually. However, more troubling is the impact this disease has on individual health and mortality. Diet and exercise have fallen short at combatting the growing prevalence of obesity, emphasizing the need for alternative treatment options. Recent research highlights the potential therapeutic effect of probiotics. Specifically, there is an abundance of research supporting the anti-obesity effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055). Here, we aimed to critically evaluate two of the studies supporting these findings. We conclude that LG2055 holds therapeutic potential for obesity, however more research is needed to substantiate this claim.